Working Group Meeting, September 10-11, 2012 Agenda
This website is archived for historical purposes and is no longer being maintained or updated.
Atlanta, Georgia
Monday, September 10 | ||
---|---|---|
Time | Activity | Speaker |
8:30 | Closed Session called to order | Ned Calonge, Chair |
8:30– 8:45 | Welcome and Opening Statement | Ned Calonge |
8:45 - 9:00 | Status updates and review of briefing book materials | Dave Dotson |
9:00 - 9:15 | CDC updates | Muin Khoury |
9:15 - 10:15 | Whole Genome Sequencing discussion |
Katrina Goddard & Ned Calonge |
10:15 - 10:30 | Break | |
10:30 - 12:00 | Familial Hypercholesterolemia | Katrina Goddard |
12:00 - 1:00 | Lunch | |
1:00 - 2:00 | CYP2C19 Testing/Anti-platelet therapy (Clopidigrel) – review & recommendation |
EPC Representative & Michael Douglas |
2:00 - 3:30 | CRC collaboration planning discussion |
Muin Khoury & Ned Calonge |
3:30 - 3:45 | Break | |
3:45 - 5:00 | CRC collaboration planning (continued) | Dave Dotson |
5:00 - 5:15 | Wrap-up and Adjourn Closed Session | Ned Calonge |
Tuesday, September 11 | ||
---|---|---|
Time | Activity | Speaker |
9:00 |
Open Session called to order | Ned Calonge |
9:00 – 9:15 | Overview of Day 1, brief staff updates and outstanding questions | Ned Calonge & Staff |
9:15 – 9:45 | CYP450 Update Report | Dave Dotson |
9:45 – 10:15 | Prostate Cancer SNP Panel Recommendation | Dave Dotson |
10:15 – 10:45 | Break | |
10:45 – 11:45 | Prostate Cancer / PCA3 - review & recommendation |
Glenn Palomaki & Michael Douglas |
11:45 – 12:00 | Public Comment | |
12:00 – 1:00 | Wrap Up and Action Items | Ned Calonge & Staff |
1:00 | Adjourn CLOSED SESSION | Ned Calonge |
- Page last reviewed: October 12, 2013 (archived document)
- Content source:
- Centers for Disease Control and Prevention
- Page maintained by: Office of Associate Director of Communication, Division of Public Affairs